Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-072739·BRIGHT MINDS BIOSCIENCES INC.
Schedule 13G ownership disclosure
Bright Minds Biosciences Inc
Common Shares, without par value · CUSIP: 10919W405
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 444,649 · Class: 6.3%
- Joseph Edelman
Shares: 444,649 · Class: 6.3%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 444,649 · Class: 6.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-072739
- Form type
- SCHEDULE 13G/A
- Filer
- BRIGHT MINDS BIOSCIENCES INC.
- CIK
- CIK 1827401
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership